Literature DB >> 21197592

A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.

Murat Albayrak1, Ozlem Sahin Balcik, Saadet Alan, Suleyman Lütfü Dıncer, Meltem Kurt Yüksel, Aynur Albayrak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21197592     DOI： 10.1007/s12253-010-9324-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  12 in total

1.  Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.

Authors:  Emilio Iannitto; Vincenzo Barbera; Gerlando Quintini; Sonia Cirrincione; Monica Leone
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

2.  Case report: a common presentation of a rare disease-hepatosplenic T-cell lymphoma.

Authors:  Jamalah Munir; Glenn Preston; Roger Polish
Journal:  Hawaii Med J       Date:  2004-11

3.  Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone.

Authors:  Maria Luisa Moleti; Anna Maria Testi; Fiorina Giona; Angela Amendola; Giovanna Palumbo; Stefania Uccini; Irene Della Starza; Maria Stefania de Propris; Anna Guarini; Robin Foà
Journal:  Leuk Lymphoma       Date:  2006-02

4.  Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.

Authors:  G Jaeger; F Bauer; R Brezinschek; C Beham-Schmid; C Mannhalter; P Neumeister
Journal:  Ann Oncol       Date:  2008-03-28       Impact factor: 32.976

Review 5.  Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990.

Authors:  E Weidmann
Journal:  Leukemia       Date:  2000-06       Impact factor: 11.528

6.  Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.

Authors:  Gaetano Corazzelli; Gaetana Capobianco; Filippo Russo; Ferdinando Frigeri; Donatella Aldinucci; Antonio Pinto
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

7.  True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases.

Authors:  C Copie-Bergman; A C Wotherspoon; A J Norton; T C Diss; P G Isaacson
Journal:  Am J Surg Pathol       Date:  1998-11       Impact factor: 6.394

8.  A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.

Authors:  S Mittal; B J Milner; P W Johnston; D J Culligan
Journal:  Eur J Haematol       Date:  2006-03-17       Impact factor: 2.997

9.  Hepatosplenic gammadelta T-cell lymphoma: A case report.

Authors:  H J Meulenbeld; W Spiering; P Nooijen; W Peters; G J Creemers
Journal:  Eur J Intern Med       Date:  2007-05       Impact factor: 4.487

Review 10.  Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

Authors:  Karim Belhadj; Felix Reyes; Jean-Pierre Farcet; Herve Tilly; Christian Bastard; Regis Angonin; Eric Deconinck; Frederic Charlotte; Veronique Leblond; Eric Labouyrie; Pierre Lederlin; Jean-Francois Emile; Beatrice Delmas-Marsalet; Bertrand Arnulf; Elie-Serge Zafrani; Philippe Gaulard
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.